dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | McDermott, David F. |
dc.contributor.author | Lee, Jae-Lyun |
dc.contributor.author | Ziobro, Marek |
dc.contributor.author | Suárez Rodríguez, Cristina |
dc.contributor.author | Langiewicz, Przemyslaw |
dc.contributor.author | Matveev, Vsevolod Borisovich |
dc.date.accessioned | 2021-07-21T10:30:49Z |
dc.date.available | 2021-07-21T10:30:49Z |
dc.date.issued | 2021-03-20 |
dc.identifier.citation | McDermott DF, Lee JL, Ziobro M, Suarez C, Langiewicz P, Matveev VB, et al. Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma. J Clin Oncol. 2021 Mar 20;39(9):1029-1039. |
dc.identifier.issn | 1527-7755 |
dc.identifier.uri | https://hdl.handle.net/11351/6191 |
dc.description | Carcinoma de cèl·lules renals; Pembrolizumab |
dc.language.iso | eng |
dc.publisher | American Society of Clinical Oncology |
dc.relation.ispartofseries | Journal of Clinical Oncology;39(9) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Adenocarcinoma |
dc.subject | Ronyons - Càncer |
dc.subject | Medicaments antineoplàstics - Ús terapèutic |
dc.subject.mesh | Carcinoma, Renal Cell |
dc.subject.mesh | Antineoplastic Agents |
dc.subject.mesh | /therapeutic use |
dc.title | Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1200/JCO.20.02365 |
dc.subject.decs | carcinoma de células renales |
dc.subject.decs | antineoplásicos |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://ascopubs.org/doi/full/10.1200/JCO.20.02365 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [McDermott DF] Beth Israel Deaconess Medical Center, Boston, MA. [Lee JL] Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea. [Ziobro M] Centrum Onkologii-Instytut im. Marii Sklodowskiej, Cracow, Poland. [Suarez C] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Langiewicz P] Wojskowy Instytut Medyczny Centralny Szpital Medyczny MON, Warszawa, Poland. [Matveev VB] N.N. Blokhin Russian Cancer Research Center, Moscow, Russia |
dc.identifier.pmid | 33529058 |
dc.identifier.wos | 000655499200010 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |